MeiraGTx Holdings plc Earnings Per Share, Basic and Diluted
MeiraGTx Holdings plc (MGTX) reported Earnings Per Share, Basic and Diluted of -$0.54 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-11
- MeiraGTx Holdings plc earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.54.
- MeiraGTx Holdings plc earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.26.
- MeiraGTx Holdings plc earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.17.
- MeiraGTx Holdings plc earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.69.
- MeiraGTx Holdings plc earnings per share, basic and diluted for fiscal 2020 was -$1.54.
- MeiraGTx Holdings plc earnings per share, basic and diluted for fiscal 2019 was -$1.65.
- MeiraGTx Holdings plc earnings per share, basic and diluted for fiscal 2018 was -$4.47.
- MeiraGTx Holdings plc earnings per share, basic and diluted for fiscal 2017 was -$3.72.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.54 10-Q · filed 2021-05-11 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$1.67 derived: net income ÷ weighted average shares · filed 2022-05-12 |
| 2020-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$1.54 10-K · filed 2021-03-11 |
| 2020-09-30 | -$0.17 10-Q · filed 2020-11-05 | -$0.86 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.29 10-Q · filed 2020-11-05 | -$1.44 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-06-30 | -$0.69 10-Q · filed 2020-08-06 | -$1.12 10-Q · filed 2020-08-06 | -$1.27 derived: net income ÷ weighted average shares · filed 2021-08-11 | -$1.58 derived: net income ÷ weighted average shares · filed 2021-08-11 |
| 2020-03-31 | -$0.43 10-Q · filed 2021-05-11 | -$0.58 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$1.49 derived: net income ÷ weighted average shares · filed 2021-05-11 |
| 2019-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.45 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$1.06 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$1.65 10-K · filed 2021-03-11 |
| 2019-09-30 | -$0.30 10-Q · filed 2020-11-05 | -$0.93 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$1.53 10-Q · filed 2020-11-05 | -$2.29 derived: net income ÷ weighted average shares · filed 2020-11-05 |
| 2019-06-30 | -$0.63 10-Q · filed 2020-08-06 | -$1.26 10-Q · filed 2020-08-06 | -$2.03 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$2.63 derived: net income ÷ weighted average shares · filed 2020-08-06 |
| 2019-03-31 | -$0.62 10-Q · filed 2020-05-07 | -$1.41 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$2.00 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$3.59 derived: net income ÷ weighted average shares · filed 2020-05-07 |
| 2018-12-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$3.04 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$4.47 10-K · filed 2020-03-11 |
| 2018-09-30 | -$0.59 10-Q · filed 2019-11-07 | -$2.33 derived: net income ÷ weighted average shares · filed 2019-11-07 | -$3.89 10-Q · filed 2019-11-07 | -$5.06 derived: net income ÷ weighted average shares · filed 2019-11-07 |
| 2018-06-30 | -$2.29 10-Q · filed 2019-08-07 | -$4.27 10-Q · filed 2019-08-07 | -$5.51 derived: net income ÷ weighted average shares · filed 2019-08-07 | -$6.63 derived: net income ÷ weighted average shares · filed 2019-08-07 |
| 2018-03-31 | -$1.91 10-Q · filed 2019-05-14 | -$2.98 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$3.99 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$4.85 derived: net income ÷ weighted average shares · filed 2019-05-14 |
| 2017-12-31 | -$1.06 derived: net income ÷ weighted average shares · filed 2019-03-26 | -$2.06 derived: net income ÷ weighted average shares · filed 2019-03-26 | -$2.91 derived: net income ÷ weighted average shares · filed 2019-03-26 | -$3.72 10-K · filed 2019-03-26 |
| 2017-09-30 | -$1.00 10-Q · filed 2018-11-08 | -$1.85 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$2.66 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$0.85 10-Q · filed 2018-08-08 | -$1.64 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |